FabOvar

Business Data, Corporate Office and Headquarter Address

About

FabOvar is Buildings and Property in Italy that focus on monoclonal antibody fragment business. They cover business area such as prevention, ovarian carcinoma.

Business Type

Buildings and Property

Country

Italy

Founded

-

Company Focus

Monoclonal Antibody Fragment

Website

-

Corporate Office and Headquarter Office address:

Via Santa Lucia, 6
20122 Milan
Italy

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

preventionovarian carcinoma

* We use standard office opening hours in near FabOvar's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

FabOvar Frequently Asked Questions

What or who is FabOvar?

FabOvar is Buildings and Property business from Italy that founded in - ( years old in ), FabOvar business is focusing on Monoclonal Antibody Fragment.

Where is FabOvar headquarter and corporate office address?

FabOvar headquarter office and corporate office address is located in Via Santa Lucia, 6 20122 Milan Italy.

Where is FabOvar country origins?

FabOvar was founded in Italy.

What is Monoclonal Antibody Fragment business focus on?

In , FabOvar is currently focus on monoclonal antibody fragment sector.

Monoclonal Antibody Fragment Business Interest from Google Trend

Above is snippet of Google Trends for "monoclonal antibody fragment" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with FabOvar, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.